Solid Biosciences Inc. (NASDAQ:SLDB) went up to recover about 5.54% since recording its record low price of $5.23. The stock experienced -3.66% slump, arriving at $5.52 on 5/24/2019. During the day, the stock price traveled from $5.4 to $5.86. This company shares are 70.65% off its target price of $9.42 and the current market capitalization stands at $202.92M. The recent change has given its price a -38.66% deficit over SMA 50 and -89.93% deficit over its 52-week high. The stock witnessed -41.59% declines, -43.79% declines and -83.28% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found SLDB’s volatility during a week at 7.93% and during a month it has been found around 8.52%.

Solid Biosciences Inc. (SLDB) Top Holders

Institutional investors currently hold around $116 million or 68.6% in SLDB stock. Look at its top three institutional owners: Perceptive Advisors Llc owns $21.68 million in Solid Biosciences Inc., which represents roughly 10.68% of the company’s market cap and approximately 18.69% of the institutional ownership. Similar statistics are true for the second largest owner, Boxer Capital, Llc, which owns 3,473,272 shares of the stock are valued at $19.17 million. The third largest holder is Ra Capital Management, Llc, which currently holds $14.85 million worth of this stock and that ownership represents nearly 7.32% of its market capitalization.

Solid Biosciences Inc. 13F Filings

At the end of March reporting period, 47 institutional holders increased their position in Solid Biosciences Inc. (NASDAQ:SLDB) by some 4,138,695 shares, 37 decreased positions by 7,288,894 and 12 held positions by 9,612,021. That puts total institutional holdings at 21,039,610 shares, according to SEC filings. The stock grabbed 22 new institutional investments totaling 1,559,419 shares while 21 institutional investors sold out their entire positions totaling 4,500,849 shares.

Solid Biosciences Inc. (NASDAQ:SLDB) Insider Trades

Multiple company employees have indulged in significant insider trading. Solid Biosciences Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Zarur Juan Andrey has sold 8,000 shares of Solid Biosciences Inc. (SLDB) in the trading session dated May. 08, 2019. These shares are worth $80,000 and were traded at $10 each. The SEC filing shows that Boxer Capital, LLC performed a sale of 450,000 shares. The 10% Owner disposed these shares by way of transaction on Mar. 28, 2019. The company’s shares were given away at $9.88 per share worth to an income of some $4,446,000 to the account of Boxer Capital, LLC.

Director, Arnold Matthew Bennett, sold 5,000 common shares of Solid Biosciences Inc. (SLDB) in the open market. In a transaction dated Jan. 14, 2019, the shares were put up for sale at an average price of $32, raking in a sum of $160,000. After this sale, 3,386,293 common shares of SLDB are directly owned by the insider, with total stake valued at $18,692,337.

In the transaction dated Jan. 07, 2019, a great number of shares sold came courtesy the Director; Arnold Matthew Bennett disposed a total of 5,000 shares at an average price of $30.08, amounting to approximately $150,400. The insider now directly owns 3,391,293 shares worth $18,719,937.

Solid Biosciences Inc. (SLDB) Analyst Guide

Several analysts have released their opinion on Solid Biosciences Inc. (NASDAQ:SLDB), with 0 analysts believing it is a strong buy. Whereas 4 of them predict the stock is a hold. Also, there are 0 buy, 3 sell and 0 strong sell ratings, collectively assigning a 3.43 average brokerage recommendation [T1].